Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
Embargo Lift Date
MetadataShow full item record
The present research work involves the formulation and development of rivastigmine and coumarin-6 loaded biodegradable Polylactide-co-glycolic acid nanoparticles attached with single and double nasal mucosa/brain targeting ligands. The developed nanocarrier systems were formulated by a solvent evaporation method and have a particle size of 189-242 nm and drug loading of 3.4%. These systems showed sustained drug release and brain targeting ability. When tested on rats via intranasal administration, 2.2 and 3.3 folds increase in brain targeting with single and dual ligands nanoparticles respectively in comparison to the drug solution. Our study supports the use of sustained release nanoparticles with dual ligands, in conjunction with intranasal administration to achieve better brain targeting efficiency.
Showing items related by title, author, creator and subject.
D'Souza, C.; Chopra, V.; Varhol, Richard; Xie, Y.; Bohacec, S.; Zhao, Y.; Lee, L.; Bilenky, M.; Portales-Casamar, E.; He, A.; Wasserman, W.; Goldowitz, D.; Marra, M.; Holt, R.; Simpson, E.; Jones, S. (2008)Background: The Pleiades Promoter Project aims to improve gene therapy by designing human mini-promoters (< 4 kb) that drive gene expression in specific brain regions or cell-types of therapeutic interest. Our goal was ...
Zhang, S.; Chen, Y.; Liang, J.; Wang, Shaobin; Liu, Lihong; Liu, Shaomin (2017)© 2017 American Scientific Publishers All rights reserved. Meningitis and encephalitis caused by bacteria and fungi are among the top 10 lethal types of infectious diseases. The treatment of brain infection is principally ...
Fakhoury, M.; Takechi, Ryu; Al-Salami, Hani (2015)The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blood vascular system. Its main role is to protect the brain and the central nervous system from external fluctuations in ...